Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Am J Transplant. 2018 Sep 17;19(3):633–645. doi: 10.1111/ajt.15072

Figure 7.

Figure 7.

Graft infiltrating C5ar1fl/fl and C5ar1fl/flxLysM-Cre Ly6Clo myeloid cells exhibit equivalent suppressive capacities and rates of apoptosis. A. Heatmap depicting expression levels for MREG-produced genes involved in suppressive function (see Figure 5 for details, n=3–4/group). B. Representative flow cytometry plots of unstimulated or anti-CD3 stimulated WT T cells ± flow sorted CD11b+Ly6CloLy6G- myeloid cells (200,000 T cells, 50,000 CD11c+ APCs and 50,000 myeloid cells) isolated from allografts on day 6 of MR1-treated C5ar1fl/fl (controls) or C5ar1fl/flxLySM-Cre recipients, illustrating suppressive ability of myeloid cells from both genotypes. Representative of results from 2 independent experiments. C. Heatmap depicting expression levels genes involved in cell death/survival (see Figure 5 for details, n=3–4/group). D-E. Representative flow cytometry plot (D) and quantified results (E) depicting frequency of apoptotic (AnnexinV+) CD11b+ Ly6Clo graft-infiltrating cells. *p<0.05, ns=not significant.